Presbyopia-correcting drops lead coverage coming into Presbyopia Awareness Month
New drug applications for two presbyopia-correcting drops and surgical management options have led presbyopia coverage so far this year.
Read more stories below to mark Presbyopia Awareness Month:
Allergan submits NDA for presbyopia-correcting drop
Allergan has submitted a new drug application for its investigational presbyopia treatment and expects action on the NDA from the FDA by the end of the year. Read more.
FDA accepts IND for presbyopia drop
The FDA has accepted an investigational new drug application for Brimochol, according to a press release from Visus Therapeutics. Read more.
BLOG: The 50+ LASIK consult
A patient calls your office to make an appointment for a LASIK consultation. She has finally decided to do something about her vision, but she is 55 years old. What do you do? Read more.
Exchangeable IOLs may be option for presbyopia management
Easily exchangeable IOLs and more advanced accommodating IOLs may be on the horizon for presbyopia management, according to speakers on the clinical panel at the virtual Ophthalmology Innovation Summit Presbyopia Innovation Showcase. Read more.
Drip drop, tick tock: Are presbyopia drops turning back the clock?
As far back as we can remember as premium surgeons, time still remains important, especially for our aging presbyopic population of patients. Read more.